These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1623 related articles for article (PubMed ID: 26710111)

  • 1. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
    Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
    J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.
    Dohler F; Sepulveda-Falla D; Krasemann S; Altmeppen H; Schlüter H; Hildebrand D; Zerr I; Matschke J; Glatzel M
    Brain; 2014 Mar; 137(Pt 3):873-86. PubMed ID: 24519981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble Prion Peptide 107-120 Protects Neuroblastoma SH-SY5Y Cells against Oligomers Associated with Alzheimer's Disease.
    Rezvani Boroujeni E; Hosseini SM; Fani G; Cecchi C; Chiti F
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dextran sulfate sodium inhibits amyloid-β oligomer binding to cellular prion protein.
    Aimi T; Suzuki K; Hoshino T; Mizushima T
    J Neurochem; 2015 Aug; 134(4):611-7. PubMed ID: 25963375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aβ induces its own prion protein N-terminal fragment (PrPN1)-mediated neutralization in amorphous aggregates.
    Béland M; Bédard M; Tremblay G; Lavigne P; Roucou X
    Neurobiol Aging; 2014 Jul; 35(7):1537-48. PubMed ID: 24602510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular prion protein as a therapeutic target in Alzheimer's disease.
    Laurén J
    J Alzheimers Dis; 2014; 38(2):227-44. PubMed ID: 23948943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of prion protein-derived peptides of potential use in Alzheimer's disease therapy.
    Nieznanska H; Bandyszewska M; Surewicz K; Zajkowski T; Surewicz WK; Nieznanski K
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2143-2153. PubMed ID: 29604335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular prion protein targets amyloid-β fibril ends via its C-terminal domain to prevent elongation.
    Bove-Fenderson E; Urano R; Straub JE; Harris DA
    J Biol Chem; 2017 Oct; 292(41):16858-16871. PubMed ID: 28842494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound-mediated augmented exosome release from astrocytes alleviates amyloid-β-induced neurotoxicity.
    Deng Z; Wang J; Xiao Y; Li F; Niu L; Liu X; Meng L; Zheng H
    Theranostics; 2021; 11(9):4351-4362. PubMed ID: 33754065
    [No Abstract]   [Full Text] [Related]  

  • 10. Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Aβ oligomers: Implications for novel therapeutic strategy in Alzheimer's disease.
    Scott-McKean JJ; Surewicz K; Choi JK; Ruffin VA; Salameh AI; Nieznanski K; Costa ACS; Surewicz WK
    Neurobiol Dis; 2016 Jul; 91():124-131. PubMed ID: 26949218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's amyloid-β oligomers rescue cellular prion protein induced tau reduction via the Fyn pathway.
    Chen RJ; Chang WW; Lin YC; Cheng PL; Chen YR
    ACS Chem Neurosci; 2013 Sep; 4(9):1287-96. PubMed ID: 23805846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between prion proteins and Aβ₁₋₄₂ oligomers in cytotoxicity and apoptosis.
    Hyeon JW; Kim SY; Park JS; Choi BY; Lee SM; Ju YR; An SS; Kim CK
    Biochem Biophys Res Commun; 2012 Jul; 424(2):214-20. PubMed ID: 22743555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic and standardized comparison of reported amyloid-β receptors for sufficiency, affinity, and Alzheimer's disease relevance.
    Smith LM; Kostylev MA; Lee S; Strittmatter SM
    J Biol Chem; 2019 Apr; 294(15):6042-6053. PubMed ID: 30787106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of cellular prion protein within β-amyloid oligomer plaques in aged human brains.
    Takahashi RH; Yokotsuka M; Tobiume M; Sato Y; Hasegawa H; Nagao T; Gouras GK
    Brain Pathol; 2021 Sep; 31(5):e12941. PubMed ID: 33624334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid-beta oligomers increase the localization of prion protein at the cell surface.
    Caetano FA; Beraldo FH; Hajj GN; Guimaraes AL; Jürgensen S; Wasilewska-Sampaio AP; Hirata PH; Souza I; Machado CF; Wong DY; De Felice FG; Ferreira ST; Prado VF; Rylett RJ; Martins VR; Prado MA
    J Neurochem; 2011 May; 117(3):538-53. PubMed ID: 21352228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-prion RNA aptamer R12 disrupts the Alzheimer's disease-related complex between prion and amyloid β.
    Iida M; Mashima T; Yamaoki Y; So M; Nagata T; Katahira M
    FEBS J; 2019 Jun; 286(12):2355-2365. PubMed ID: 30916478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes and the Prion Protein: More than One Truth.
    Hartmann A; Muth C; Dabrowski O; Krasemann S; Glatzel M
    Front Neurosci; 2017; 11():194. PubMed ID: 28469550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's Aβ interacts with cellular prion protein inducing neuronal membrane damage and synaptotoxicity.
    Peters C; Espinoza MP; Gallegos S; Opazo C; Aguayo LG
    Neurobiol Aging; 2015 Mar; 36(3):1369-77. PubMed ID: 25599875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease pathology propagation by exosomes containing toxic amyloid-beta oligomers.
    Sardar Sinha M; Ansell-Schultz A; Civitelli L; Hildesjö C; Larsson M; Lannfelt L; Ingelsson M; Hallbeck M
    Acta Neuropathol; 2018 Jul; 136(1):41-56. PubMed ID: 29934873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons.
    Um JW; Nygaard HB; Heiss JK; Kostylev MA; Stagi M; Vortmeyer A; Wisniewski T; Gunther EC; Strittmatter SM
    Nat Neurosci; 2012 Sep; 15(9):1227-35. PubMed ID: 22820466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 82.